The fibroblast growth factor-2 antisense gene inhibits nuclear accumulation of FGF-2 and delays cell cycle progression in C6 glioma cells

Molecular and Cellular Endocrinology

Volumn 267, Issue 1-2, 2007, Pages 127-136

  Baguma Nibasheka, Mark ^a   Li, Audrey W ^a   Murphy, Paul R ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Antisense; Cell cycle; FGF 2; Glioma

Indexed keywords

COMPLEMENTARY DNA; COMPLEMENTARY RNA; FIBROBLAST GROWTH FACTOR 2; GENE PRODUCT; ISOPROTEIN; MESSENGER RNA; NUCLEAR PROTEIN;

ANIMAL CELL; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL NUCLEUS; CELL PROLIFERATION; CELL STRAIN C6; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FGF AS GENE; GENE OVEREXPRESSION; GLIOMA CELL; HEAT SHOCK; IMMUNOREACTIVITY; NONHUMAN; NUCLEAR IMPORT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RNA GENE; STABLE TRANSFECTION; TRANSCRIPTION REGULATION; TUMOR CELL LINE;

ANIMALS; CELL CYCLE; CELL NUCLEUS; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTORS; GENE EXPRESSION; GENE EXPRESSION REGULATION; GLIOMA; PROTEIN TRANSPORT; RATS; RNA, ANTISENSE; RNA, MESSENGER; SERUM; SUBCELLULAR FRACTIONS;

EID: 33847308735     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2007.01.008     Document Type: Article

References (62)

1. Amalric F., Bouche G., Bonnet H., Brethenou P., Roman A.M., Truchet I., and Quarto N. Fibroblast growth factor-2 (FGF-2) in the nucleus: translocation process and targets. Biochem. Pharmacol. 47 (1994) 111-115
2. Arese M., Chen Y., Florkiewicz R.Z., Gualandris A., Shen B., and Rifkin D.B. Nuclear activities of basic fibroblast growth factor: potentiation of low-serum growth mediated by natural or chimeric nuclear localization signals. Mol. Biol. Cell 10 (1999) 1429-1444
3. Arnaud E., Touriol C., Boutonnet C., Gensac M.-C., Vagner S., Prats H., and Prats A.-C. A new 34-kilodalton isoform of human fibroblast growth factor 2 is cap dependently synthesized by using a non-AUG start codon and behaves as a survival factor. Mol. Cell. Biol. 19 (1999) 505-514
4. Asa S.L., Ramyar L., Murphy P.R., Li A.W., and Ezzat S. The endogenous fibroblast growth factor-2 antisense gene product regulates pituitary cell growth and hormone production. Mol. Endocrinol. 15 (2001) 589-599
5. Baguma-Nibasheka M., Li A.W., Osman M.S., Geldenhuys L., Casson A.G., Too C.K., and Murphy P.R. Coexpression and regulation of the FGF-2 and FGF antisense genes in leukemic cells. Leuk. Res. 29 (2005) 423-433
6. Bailly K., Soulet F., Leroy D., Amalric F., and Bouche G. Uncoupling of cell proliferation and differentiation activities of basic fibroblast growth factor. FASEB J. 14 (2000) 333-344
7. Baldin V., Roman A.M., Bosc-Bierne I., Amalric F., and Bouche G. Translocation of bFGF to the nucleus is G1 phase cell cycle specific in bovine aortic endothelial cells. EMBO J. 9 (1990) 1511-1517
8. Barclay C., Li A.W., Geldenhuys L., Baguma-Nibasheka M., Porter G.A., Veugelers P.J., Murphy P.R., and Casson A.G. Basic fibroblast growth factor (FGF-2) overexpression is a risk factor for esophageal cancer recurrence and reduced survival, which is ameliorated by coexpression of the FGF-2 antisense gene. Clin. Cancer Res. 11 (2005) 7683-7691
9. Bessman M.J., Frick D.N., and O'Handley S.F. The MutT proteins or "nudix" hydrolases, a family of versatile, widely distributed, "housecleaning" enzymes. J. Biol. Chem. 271 (1996) 25059-25062
10. Bossard C., Laurell H., Van den Berghe L., Meunier S., Zanibellato C., and Prats H. Translokin is an intracellular mediator of FGF-2 trafficking. Nat. Cell Biol. 5 (2003) 433-439
11. Bouche G., Gas N., Prats H., Baldin V., Tauber J., Teissie J., and Almaric F. Basic fibroblast growth factor enters the nucleolus and stimulates the transcription of ribosomal genes in ABAE cells undergoing G0-G1 transition. Proc. Natl. Acad. Sci. U.S.A. 84 (1987) 6770-6774
12. Bouche G., Baldin V., Belenguer P., Prats H., and Amalric F. Activation of rDNA transcription by FGF-2: key role of protein kinase CKII. Cell. Mol. Biol. Res. 40 (1994) 547-554
13. Boulle N., Jones E.M., Auguste P., and Baird A. Adenosine diphosphate ribosylation of fibroblast growth factor-2. Mol. Endocrinol. 9 (1995) 767-775
14. Bredel M., Pollack I.F., Campbell J.W., and Hamilton R.L. Basic fibroblast growth factor expression as a predictor of prognosis in pediatric high-grade gliomas. Clin. Cancer Res. 3 (1997) 2157-2164
15. Claus P., Doring F., Gringel S., Muller-Ostermeyer F., Fuhlrott J., Kraft T., and Grothe C. Differential intranuclear localization of fibroblast growth factor-2 isoforms and specific interaction with the survival of motoneuron protein. J. Biol. Chem. 278 (2003) 479-485
16. Dell'Era P., Presta M., and Ragnotti G. Nuclear localization of endogenous basic fibroblast growth factor in cultured endothelial cells. Exp. Cell Res. 192 (1991) 505-510
17. Delrieu I. The high molecular weight isoforms of basic fibroblast growth factor (FGF-2): an insight into an intracrine mechanism. FEBS Lett. 468 (2000) 6-10
18. Eckenstein F.P. Fibroblast growth factors in the nervous system. J. Neurobiol. 25 (1994) 1467-1480
19. Erdos G., Lee Y.J., Cho J.M., and Corry P.M. Heat-induced bFGF gene expression in the absence of heat shock element correlates with enhanced AP-1 binding activity. J. Cell. Physiol. 164 (1995) 404-413
20. Feige J.-J., and Baird A. Basic fibroblast growth factor is a substrate for protein phosphorylation and is phosphorylated by capillary endothelial cells in culture. Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 3174-3188
21. Finklestein S.P., Apostolides P.J., Caday C.G., Prosser J., Philips M.F., and Klagsbrun M. Increased basic fibroblast growth factor (bFGF) immunoreactivity at the site of focal brain wounds. Brain Res. 460 (1988) 253-259
22. Frautschy S.A., Walicke P.A., and Baird A. Localization of basic fibroblast growth factor and its messenger RNA after CNS injury. Brain Res. 553 (1991) 291-299
23. Fukui S., Nawashiro H., Otani N., Ooigawa H., Nomura N., Yano A., Miyazawa T., Ohnuki A., Tsuzuki N., Katoh H., Ishihara S., and Shima K. Nuclear accumulation of basic fibroblast growth factor in human astrocytic tumors. Cancer 97 (2003) 3061-3067
24. Gagnon M.L., Moy G.K., and Klagsbrun M. Characterization of the promoter for the human antisense fibroblast growth factor-2 gene; regulation by Ets in Jurkat T cells. J. Cell. Biochem. 72 (1999) 492-506
25. Grothe C., and Meisinger C. Fibroblast growth factor (FGF)-2 sense and antisense mRNA and FGF receptor type 1 mRNA are present in the embryonic and adult rat nervous system. Neurosci. Lett. 197 (1995) 175-178
26. Hawker Jr. J.R., and Granger H.J. Internalized basic fibroblast growth factor translocates to nuclei of venular endothelial cells. Am. J. Physiol. 262 (1992) H1525-H1537
27. Kevil C., Carter P., Hu B., and DeBenedetti A. Translational enhancement of FGF-2 by eIF-4 factors, and alternate utilization of CUG and AUG codons for translation initiation. Oncogene 11 (1995) 2339-2348
28. Kimelman D., and Kirschner M.W. An antisense messenger RNA directs the covalent modification of the transcript encoding fibroblast growth factor in Xenopus oocytes. Cell 59 (1989) 687-696
29. Knee R., Li A.W., and Murphy P.R. Characterization and tissue-specific expression of the rat basic fibroblast growth factor antisense mRNA and protein. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 4943-4947
30. Knee R.S., Pitcher S.E., and Murphy P.R. Basic fibroblast growth factor sense (FGF) and antisense (gfg) RNA transcripts are expressed in unfertilized human oocytes and in differentiated adult tissues. Biochem. Biophys. Res. Commun. 205 (1994) 577-583
31. Kumar M., and Carmichael G.G. Nuclear antisense RNA induces extensive adenosine modifications and nuclear retention of target transcripts. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 3542-3547
32. Li A.W., Too C.K.L., Knee R., Wilkinson M., and Murphy P.R. FGF-2 antisense RNA encodes a nuclear protein with MutT-like antimutator activity. Mol. Cell. Endocrinol. 133 (1997) 177-182
33. Li A.W., and Murphy P.R. Expression of alternatively spliced FGF-2 antisense RNA transcripts in the central nervous system: regulation of FGF-2 mRNA translation. Mol. Cell. Endocrinol. 170 (2000) 233-242
34. Lorenz P., Pepperkok R., and Pyerin W. Requirement of casein kinase 2 for entry into and progression through early phases of the cell cycle. Cell. Mol. Biol. Res. 40 (1994) 519-527
35. Mignatti P., Morimoto T., and Rifkin D.B. Basic fibroblast growth factor, a protein devoid of secretory signal sequence, is released by cells via a pathway independent of the endoplasmic reticulum-golgi complex. J. Cell. Physiol. 151 (1992) 81-93
36. Mihalich A., Reina M., Mangioni S., Ponti E., Alberti L., Vigano P., Vignali M., and Di Blasio A.M. Different basic fibroblast growth factor and fibroblast growth factor-antisense expression in eutopic endometrial stromal cells derived from women with and without endometriosis. J. Clin. Endocrinol. Metab. 88 (2003) 2853-2859
37. Morrison R.S. Suppression of basic fibroblast growth factor expression by antisense oligodeoxynucleotides inhibits the growth of transformed human astrocytes. J. Biol. Chem. 266 (1991) 728-734
38. Morrison R.S., Yamaguchi F., Saya H., Bruner J.M., Yahanda A.M., Donehower L.A., and Berger M. Basic fibroblast growth factor and fibroblast growth factor receptor I are implicated in the growth of human astrocytomas. J. Neurooncol. 18 (1994) 207-216
39. Murphy P., Sato Y., and Knee R. Phosphorothioate antisense oligonucleotides against basic fibroblast growth factor inhibit anchorage-dependent and anchorage-independent growth of a malignant glioblastoma cell line. Mol. Endocrinol. 6 (1992) 877-884
40. Murphy P.R., Myal Y., Sato Y., Sato R., West M., and Friesen H.G. Elevated expression of basic fibroblast growth factor messenger ribonucleic acid in acoustic neuromas. Mol. Endocrinol. 3 (1989) 225-231
41. Murphy P.R., and Knee R.S. Identification and characterization of an antisense RNA transcript (gfg) from the basic fibroblast growth factor gene in human and rat cells. Mol. Endocrinol. 8 (1994) 852-859
42. Murphy P.R., and Knee R.S. Basic fibroblast growth factor binding and processing by human glioma cells. Mol. Cell. Endocrinol. 114 (1995) 193-203
43. Murphy P.R., Limoges M., Dodd F., Boudreau R.T., and Too C.K. Fibroblast growth factor-2 stimulates endothelial nitric oxide synthase expression and inhibits apoptosis by a nitric oxide-dependent pathway in Nb2 lymphoma cells. Endocrinology 142 (2001) 81-88
44. Ogawa T., Ueda Y., Yoshimura K., and Shigeoka S. Comprehensive analysis of cytosolic nudix hydrolases in Arabidopsis thaliana. J. Biol. Chem. 280 (2005) 25277-25283
45. Paul M.S., and Bass B.L. Inosine exists in mRNA at tissue-specific levels and is most abundant in brain mRNA. EMBO J. 17 (1998) 1120-1127
46. Pepperkok R., Lorenz P., Ansorge W., and Pyerin W. Casein kinase II is required for transition of G0/G1, early G1, and G1/S phases of the cell cycle. J. Biol. Chem. 269 (1994) 6986-6991
47. Pintucci G., Quarto N., and Rifkin D.B. Methylation of high molecular weight fibroblast growth factor-2 determines post-translational increases in molecular weight and affects its intracellular distribution. Mol. Biol. Cell 7 (1996) 1249-1258
48. Powell P., and Klagsbrun M. Regulation of basic fibroblast growth factor mRNA expression in rat C6 glioma cells. Exp. Cell Res. 209 (1993) 224-230
49. Rifkin D.B., and Moscatelli D. Recent developments in the cell biology of basic fibroblast growth factor. J. Cell Biol. 109 (1989) 1-6
50. Saccomanno l., and Bass B.L. The cytoplasm of Xenopus oocytes contains a factor that protects double-stranded RNA from adenosine -to-inosine modification. Mol. Cell. Biol. 14 (1994) 5425-5432
51. Saccomanno L., and Bass B.L. A minor fraction of basic fibroblast growth factor mRNA is deaminated in Xenopus stage VI and matured oocytes. RNA (New York, NY) 5 (1999) 39-48
52. Scadden A.D., and Smith C.W. A ribonuclease specific for inosine-containing RNA: a potential role in antiviral defence?. EMBO J. 16 (1997) 2140-2149
53. Stachowiak M.K., Moffett J., Joy A., Puchacz E., Florkiewicz R., and Stachowiak E.K. Regulation of bFGF gene expression and subcellular distribution of bFGF protein in adrenal medullary cells. J. Cell Biol. 127 (1994) 203-223
54. Szebenyi G., and Fallon J.F. Fibroblast growth factors as multifunctional signaling factors. Int. Rev. Cytol. 185 (1999) 45-106
55. Takahashi J.A., Fukumoto M., Igarashi K., Oda Y., Kikuchi H., and Hatanaka M. Correlation of basic fibroblast growth factor expression levels with the degree of malignancy and vascularity in human gliomas. J. Neurosurg. 76 (1992) 792-798
56. Touriol C., Morillon A., Gensac M.C., Prats H., and Prats A.C. Expression of human fibroblast growth factor 2 mRNA is post-transcriptionally controlled by a unique destabilizing element present in the 3′-untranslated region between alternative polyadenylation sites. J. Biol. Chem. 274 (1999) 21402-21408
57. Touriol C., Roussigne M., Gensac M.C., Prats H., and Prats A.C. Alternative translation initiation of human fibroblast growth factor 2 mRNA controlled by its 3′-untranslated region involves a Poly(A) switch and a translational enhancer. J. Biol. Chem. 275 (2000) 19361-19367
58. Vagner S., Gensac M.C., Maret A., Bayard F., Amalric F., Prats H., and Prats A.C. Alternative translation of human fibroblast growth factor 2 mRNA occurs by internal entry of ribosomes. Mol. Cell. Biol. 15 (1995) 35-44
59. Vagner S., Touriol C., Galy B., Audigier S., Gensac M.-C., Almaric F., Bayard F., Prats H., and Prats A.-C. Translation of CUG- but not AUG-initiated forms of human fibroblast growth factor 2 is activated in transformed and stressed cells. J. Cell Biol. 135 (1996) 1391-1404
60. Westermann R., and Unsicker K. Basic fibroblast growth factor (bFGF) and rat C6 glioma cells: regulation of expression, absence of release, and response to exogenous bFGF. Glia 3 (1990) 510-521
61. Zagzag D., Miller D.C., Sato Y., Rifkin D.B., and Burstein D.E. Immunohistochemical localization of basic fibroblast growth factor in astrocytomas. Cancer Res. 50 (1990) 7393-7398
62. Zuniga Mejia Borja A., Meijers C., and Zeller L. Expression of alternatively spliced bFGF first coding exons and antisense mRNAs during chicken embryogenesis. Dev. Biol. 157 (1993) 110-118